DGAP-News: MorphoSys to Present at Upcoming Virtual Investor Conferences

In 2017, Tremfya(R), marketed by Janssen for the treatment of plaque psoriasis, became the first drug based on MorphoSys' antibody technology to receive regulatory approval.